0 XP   0   0   0

Synthetic Biologics Inc
Buy, Hold or Sell?

I guess you are interested in Synthetic Biologics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Synthetic Biologics Inc

Let's start. I'm going to help you getting a better view of Synthetic Biologics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Synthetic Biologics Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Synthetic Biologics Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Synthetic Biologics Inc. The closing price on 2022-09-30 was $0.986 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Synthetic Biologics Inc Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Synthetic Biologics Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Synthetic Biologics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Synthetic Biologics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Synthetic Biologics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--241.1%+241.1%
TTM--275.9%+275.9%
YOY--342.1%+342.1%
5Y--475.7%+475.7%
10Y--561.7%+561.7%
1.1.2. Return on Assets

Shows how efficient Synthetic Biologics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Synthetic Biologics Inc to the Biotechnology industry mean.
  • -5.7% Return on Assets means that Synthetic Biologics Inc generated $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Synthetic Biologics Inc:

  • The MRQ is -6.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.0%TTM-5.7%-0.4%
TTM-5.7%YOY-15.4%+9.7%
TTM-5.7%5Y-17.7%+12.1%
5Y-17.7%10Y-34.5%+16.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.0%-9.7%+3.7%
TTM-5.7%-8.7%+3.0%
YOY-15.4%-9.2%-6.2%
5Y-17.7%-11.5%-6.2%
10Y-34.5%-12.4%-22.1%
1.1.3. Return on Equity

Shows how efficient Synthetic Biologics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Synthetic Biologics Inc to the Biotechnology industry mean.
  • -8.1% Return on Equity means the company generated $-0.08 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Synthetic Biologics Inc:

  • The MRQ is -8.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.1%TTM-6.7%-1.3%
TTM-6.7%YOY-16.3%+9.6%
TTM-6.7%5Y-19.3%+12.5%
5Y-19.3%10Y-44.4%+25.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.1%-11.8%+3.7%
TTM-6.7%-11.0%+4.3%
YOY-16.3%-10.6%-5.7%
5Y-19.3%-13.5%-5.8%
10Y-44.4%-14.5%-29.9%

1.2. Operating Efficiency of Synthetic Biologics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Synthetic Biologics Inc is operating .

  • Measures how much profit Synthetic Biologics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Synthetic Biologics Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Synthetic Biologics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.1%+232.1%
TTM--269.6%+269.6%
YOY--309.3%+309.3%
5Y--466.7%+466.7%
10Y--572.5%+572.5%
1.2.2. Operating Ratio

Measures how efficient Synthetic Biologics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.0% means that the operating costs are $0.00for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Synthetic Biologics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.321-3.321
TTM-3.542-3.542
YOY-3.491-3.491
5Y-5.744-5.744
10Y-7.007-7.007

1.3. Liquidity of Synthetic Biologics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Synthetic Biologics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 413.8% means the company has $4.14 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Synthetic Biologics Inc:

  • The MRQ is 4.138. The company is very able to pay all its short-term debts. +2
  • The TTM is 13.054. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.138TTM13.054-8.916
TTM13.054YOY19.499-6.445
TTM13.0545Y8.824+4.230
5Y8.82410Y9.056-0.232
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1385.266-1.128
TTM13.0546.060+6.994
YOY19.4996.365+13.134
5Y8.8246.692+2.132
10Y9.0566.457+2.599
1.3.2. Quick Ratio

Measures if Synthetic Biologics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Biotechnology industry mean)
  • A Quick Ratio of 396.1% means the company can pay off $3.96 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Synthetic Biologics Inc:

  • The MRQ is 3.961. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 12.764. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.961TTM12.764-8.802
TTM12.764YOY19.029-6.266
TTM12.7645Y8.553+4.211
5Y8.55310Y8.139+0.414
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.9613.985-0.024
TTM12.7644.865+7.899
YOY19.0295.192+13.837
5Y8.5535.275+3.278
10Y8.1394.997+3.142

1.4. Solvency of Synthetic Biologics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Synthetic Biologics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Asset Ratio of 0.25 means that Synthetic Biologics Inc assets are financed with 25.1% credit (debt) and the remaining percentage (100% - 25.1%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Synthetic Biologics Inc:

  • The MRQ is 0.251. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.154. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.251TTM0.154+0.096
TTM0.154YOY0.226-0.071
TTM0.1545Y0.356-0.201
5Y0.35610Y0.466-0.110
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2510.271-0.020
TTM0.1540.269-0.115
YOY0.2260.296-0.070
5Y0.3560.361-0.005
10Y0.4660.399+0.067
1.4.2. Debt to Equity Ratio

Measures if Synthetic Biologics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Equity ratio of 33.5% means that company has $0.33 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Synthetic Biologics Inc:

  • The MRQ is 0.335. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.195. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.335TTM0.195+0.140
TTM0.195YOY0.239-0.044
TTM0.1955Y0.280-0.085
5Y0.28010Y0.828-0.548
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3350.310+0.025
TTM0.1950.311-0.116
YOY0.2390.310-0.071
5Y0.2800.382-0.102
10Y0.8280.438+0.390

2. Market Valuation of Synthetic Biologics Inc

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Synthetic Biologics Inc.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -0.17 means the investor is paying $-0.17 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Synthetic Biologics Inc:

  • The EOD is -0.777. Company is losing money. -2
  • The MRQ is -0.168. Company is losing money. -2
  • The TTM is -0.188. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-0.777MRQ-0.168-0.609
MRQ-0.168TTM-0.188+0.020
TTM-0.188YOY-0.116-0.072
TTM-0.1885Y-0.080-0.108
5Y-0.08010Y-0.049-0.031
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.777-2.150+1.373
MRQ-0.168-2.332+2.164
TTM-0.188-3.889+3.701
YOY-0.116-5.087+4.971
5Y-0.080-3.697+3.617
10Y-0.049-3.390+3.341
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Synthetic Biologics Inc.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Synthetic Biologics Inc:

  • The MRQ is 0.003. Very good. +2
  • The TTM is 0.003. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.003TTM0.0030.000
TTM0.003YOY0.002+0.001
TTM0.0035Y0.002+0.001
5Y0.00210Y0.001+0.001
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0030.004-0.001
TTM0.0030.019-0.016
YOY0.0020.042-0.040
5Y0.0020.021-0.019
10Y0.0010.017-0.016

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Synthetic Biologics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.05 means the investor is paying $0.05 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Synthetic Biologics Inc:

  • The EOD is 0.253. Very good. +2
  • The MRQ is 0.055. Very good. +2
  • The TTM is 0.063. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.253MRQ0.055+0.199
MRQ0.055TTM0.063-0.009
TTM0.063YOY0.271-0.208
TTM0.0635Y0.096-0.032
5Y0.09610Y0.079+0.017
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.2531.816-1.563
MRQ0.0551.961-1.906
TTM0.0632.789-2.726
YOY0.2713.538-3.267
5Y0.0962.782-2.686
10Y0.0792.419-2.340

2.4. Latest News of Synthetic Biologics Inc

Does Synthetic Biologics Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Synthetic Biologics Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-09-05
14:00
Synthetic Biologics Announces Presentation at ESMO Congress 2022 Describing Phase 1 Investigator-sponsored Study Evaluating VCN-01 in Combination with Durvalumab in Patients with Recurrent/ Metastatic Squamous Cell Carcinoma of the Head and NeckRead

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Synthetic Biologics Inc.


4. Summary

4.1. Key Performance Indicators

The key performance indicators of Synthetic Biologics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--3.8934.778-19%4.162-6%6.044-36%19.855-80%
Book Value Per Share Growth---1.030-0.423-59%0.606-270%-0.227-78%-1.718+67%
Current Ratio--4.13813.054-68%19.499-79%8.824-53%9.056-54%
Debt To Asset Ratio--0.2510.154+62%0.226+11%0.356-29%0.466-46%
Debt To Equity Ratio--0.3350.195+71%0.239+40%0.280+20%0.828-60%
Dividend Per Share---0.057-100%0.285-100%0.068-100%0.034-100%
Eps---0.314-0.317+1%-0.808+158%-4.797+1430%-16.061+5022%
Eps Growth---60.730-66.788+10%-53.515-12%-50.925-16%-16.392-73%
Gains Per Share---1.030-0.366-64%0.890-216%-0.158-85%-1.684+64%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.253+78%0.0550.063-14%0.271-80%0.096-43%0.079-31%
Pe Ratio-0.777-362%-0.168-0.188+12%-0.116-31%-0.080-52%-0.049-71%
Peg Ratio--0.0030.003-1%0.002+28%0.002+72%0.001+231%
Price Per Share0.986+78%0.2130.308-31%0.536-60%0.578-63%1.175-82%
Quick Ratio--3.96112.764-69%19.029-79%8.553-54%8.139-51%
Return On Assets---0.060-0.057-6%-0.154+155%-0.177+194%-0.345+471%
Return On Equity---0.081-0.067-17%-0.163+102%-0.193+139%-0.444+452%
 EOD+1 -2MRQTTM+5 -11YOY+6 -105Y+7 -910Y+10 -6

4.2. Fundamental Score

Let's check the fundamental score of Synthetic Biologics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.777
Price to Book Ratio (EOD)Between0-10.253
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.961
Current Ratio (MRQ)Greater than14.138
Debt to Asset Ratio (MRQ)Less than10.251
Debt to Equity Ratio (MRQ)Less than10.335
Return on Equity (MRQ)Greater than0.15-0.081
Return on Assets (MRQ)Greater than0.05-0.060
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Synthetic Biologics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5024.937
Ma 20Greater thanMa 501.251
Ma 50Greater thanMa 1001.385
Ma 100Greater thanMa 2000.798
OpenGreater thanClose1.050
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets82,331
Total Liabilities20,657
Total Stockholder Equity61,674
 As reported
Total Liabilities 20,657
Total Stockholder Equity+ 61,674
Total Assets = 82,331

Assets

Total Assets82,331
Total Current Assets54,888
Long-term Assets54,888
Total Current Assets
Cash And Cash Equivalents 52,266
Net Receivables 278
Other Current Assets 2,344
Total Current Assets  (as reported)54,888
Total Current Assets  (calculated)54,888
+/-0
Long-term Assets
Property Plant Equipment 1,577
Goodwill 5,185
Intangible Assets 20,562
Long-term Assets Other 119
Long-term Assets  (as reported)27,443
Long-term Assets  (calculated)27,443
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities13,264
Long-term Liabilities7,393
Total Stockholder Equity61,674
Total Current Liabilities
Short-term Debt 184
Short Long Term Debt 56
Accounts payable 1,003
Other Current Liabilities 12,077
Total Current Liabilities  (as reported)13,264
Total Current Liabilities  (calculated)13,320
+/- 56
Long-term Liabilities
Capital Lease Obligations 1,426
Other Liabilities 5,879
Long-term Liabilities  (as reported)7,393
Long-term Liabilities  (calculated)7,305
+/- 88
Total Stockholder Equity
Common Stock16
Retained Earnings -280,525
Accumulated Other Comprehensive Income -1,317
Other Stockholders Equity 343,500
Total Stockholder Equity (as reported)61,674
Total Stockholder Equity (calculated)61,674
+/-0
Other
Capital Stock16
Cash and Short Term Investments 52,266
Common Stock Shares Outstanding 15,844
Liabilities and Stockholders Equity 82,331
Net Debt -50,568
Net Invested Capital 61,946
Net Tangible Assets 56,489
Net Working Capital 41,624
Short Long Term Debt Total 1,698



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-301993-06-301993-03-311992-12-311992-09-301992-06-301992-03-31
> Total Assets 
0
0
0
0
5,000
4,400
2,900
1,800
4,700
3,400
1,370
400
2,960
480
3,300
2,200
2,500
5,700
4,600
2,800
3,500
1,100
1,300
700
200
6,000
3,100
2,900
2,300
1,800
1,600
5,049
6,361
3,939
3,467
5,451
3,607
3,502
3,244
2,056
2,326
2,290
1,790
1,515
1,515
0
0
0
0
0
0
0
0
0
0
1,440
0
0
756
12,515
12,515
10,686
9,318
13,633
10,841
9,413
8,206
7,385
6,696
5,733
5,075
4,076
3,273
4,528
4,681
4,111
7,206
9,521
8,675
7,476
8,349
7,245
5,826
13,423
13,423
9,627
6,953
16,257
12,531
9,289
4,741
19,144
13,716
11,837
42,634
30,845
22,743
16,331
8,248
22,498
17,719
15,740
23,279
18,838
12,467
8,418
10,796
30,141
26,632
23,999
20,742
17,235
11,887
9,582
7,203
8,410
79,054
77,255
75,121
70,365
88,999
82,331
82,33188,99970,36575,12177,25579,0548,4107,2039,58211,88717,23520,74223,99926,63230,14110,7968,41812,46718,83823,27915,74017,71922,4988,24816,33122,74330,84542,63411,83713,71619,1444,7419,28912,53116,2576,9539,62713,42313,4235,8267,2458,3497,4768,6759,5217,2064,1114,6814,5283,2734,0765,0755,7336,6967,3858,2069,41310,84113,6339,31810,68612,51512,515756001,44000000000001,5151,5151,7902,2902,3262,0563,2443,5023,6075,4513,4673,9396,3615,0491,6001,8002,3002,9003,1006,0002007001,3001,1003,5002,8004,6005,7002,5002,2003,3004802,9604001,3703,4004,7001,8002,9004,4005,0000000
   > Total Current Assets 
0
0
0
0
5,000
4,400
2,900
1,700
4,600
3,310
1,230
100
2,790
310
3,200
2,000
2,100
5,200
4,300
2,500
3,300
800
1,100
500
100
5,900
2,900
2,600
2,100
1,600
1,300
4,539
5,842
3,463
2,935
4,910
3,083
2,858
2,640
1,373
1,647
1,564
1,063
835
835
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,218
12,218
9,128
7,369
11,556
8,845
7,520
6,495
5,927
5,357
4,515
3,658
2,755
2,073
3,443
3,702
3,331
6,584
8,906
8,093
7,122
7,325
6,271
4,850
12,463
12,463
9,457
6,792
16,216
12,487
9,232
4,668
19,073
13,623
11,712
42,137
30,337
22,216
15,823
7,640
21,570
16,837
14,916
22,313
17,943
11,643
7,664
10,108
29,511
25,554
23,010
19,843
16,426
11,169
8,956
6,662
7,934
78,636
75,632
73,557
68,858
59,555
54,888
54,88859,55568,85873,55775,63278,6367,9346,6628,95611,16916,42619,84323,01025,55429,51110,1087,66411,64317,94322,31314,91616,83721,5707,64015,82322,21630,33742,13711,71213,62319,0734,6689,23212,48716,2166,7929,45712,46312,4634,8506,2717,3257,1228,0938,9066,5843,3313,7023,4432,0732,7553,6584,5155,3575,9276,4957,5208,84511,5567,3699,12812,21812,218000000000000008358351,0631,5641,6471,3732,6402,8583,0834,9102,9353,4635,8424,5391,3001,6002,1002,6002,9005,9001005001,1008003,3002,5004,3005,2002,1002,0003,2003102,7901001,2303,3104,6001,7002,9004,4005,0000000
       Cash And Cash Equivalents 
0
0
0
0
4,600
4,200
2,800
1,700
4,400
3,220
1,010
100
460
130
3,000
1,900
2,000
5,200
3,500
2,000
3,000
500
1,000
400
10
5,400
2,600
2,500
1,900
1,300
800
3,874
3,488
1,846
1,644
3,042
2,381
1,464
2,118
859
1,057
856
348
327
327
0
0
0
0
0
0
0
0
0
0
1,158
0
0
0
12,192
12,192
9,111
7,352
11,493
8,762
7,453
6,436
5,856
5,289
4,423
3,532
2,715
1,979
3,271
3,305
2,649
6,080
8,386
4,609
6,678
6,802
5,932
4,577
9,954
9,954
6,877
5,145
14,625
11,155
7,843
3,286
17,525
12,049
4,757
31,806
20,818
15,100
10,049
4,549
19,055
13,471
13,376
21,050
17,116
11,037
7,129
9,549
28,918
24,694
21,712
18,650
15,045
10,085
8,059
6,005
6,227
76,887
74,291
72,135
67,325
56,692
52,266
52,26656,69267,32572,13574,29176,8876,2276,0058,05910,08515,04518,65021,71224,69428,9189,5497,12911,03717,11621,05013,37613,47119,0554,54910,04915,10020,81831,8064,75712,04917,5253,2867,84311,15514,6255,1456,8779,9549,9544,5775,9326,8026,6784,6098,3866,0802,6493,3053,2711,9792,7153,5324,4235,2895,8566,4367,4538,76211,4937,3529,11112,19212,1920001,15800000000003273273488561,0578592,1181,4642,3813,0421,6441,8463,4883,8748001,3001,9002,5002,6005,400104001,0005003,0002,0003,5005,2002,0001,9003,0001304601001,0103,2204,4001,7002,8004,2004,6000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200
200
519
2,005
1,141
921
327
301
309
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,866
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000002,86600000000000000000000000000000000000000003093013279211,1412,00551920020000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
20
100
0
0
0
300
0
0
0
0
100
100
0
0
0
0
0
0
0
0
0
0
1,000
0
762
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
49
55
45
68
99
31
89
164
387
339
429
445
495
405
440
245
122
0
700
700
0
0
0
0
0
0
0
0
0
0
0
0
0
185
185
927
742
46
0
5
86
0
6
4
4
3
0
0
0
469
469
0
0
0
1,721
278
2781,721000469469000344608650467429271851850000000000000700700012224544040549544542933938716489319968455549000000000000000000000000000076201,00000000000001001000000300000100200000000000000
       Other Current Assets 
0
0
0
0
400
200
100
0
200
90
220
-100
2,330
160
100
100
100
0
500
500
300
300
100
0
-10
500
300
100
200
100
300
145
350
476
369
540
401
324
522
514
91
708
715
0
508
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26
26
17
16
64
84
67
11
15
23
25
27
9
5
8
9
343
75
76
124
39
83
94
151
2,509
2,509
1,880
1,647
1,591
1,332
1,389
1,382
1,548
1,574
6,955
10,331
9,519
7,116
5,774
3,091
2,330
3,366
1,540
1,263
781
606
530
473
593
854
1,294
1,189
1,378
1,084
897
657
1,238
1,749
1,341
1,422
1,533
1,142
2,344
2,3441,1421,5331,4221,3411,7491,2386578971,0841,3781,1891,2948545934735306067811,2631,5403,3662,3303,0915,7747,1169,51910,3316,9551,5741,5481,3821,3891,3321,5911,6471,8802,5092,5091519483391247675343985927252315116784641617262600000000000000508071570891514522324401540369476350145300100200100300500-10010030030050050001001001001602,330-1002209020001002004000000
   > Long-term Assets 
0
0
0
0
0
0
0
100
100
90
140
300
170
170
100
200
400
500
300
300
200
300
200
200
100
100
200
300
200
200
300
510
519
476
533
541
525
644
604
683
679
727
727
0
679
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
297
1,558
1,949
2,077
1,996
1,892
1,711
1,458
1,339
1,219
1,417
1,321
1,200
1,086
979
780
621
615
582
354
1,024
974
976
960
960
170
161
41
44
57
73
71
93
125
497
508
527
508
608
928
882
824
966
895
824
754
688
630
1,078
989
899
809
718
626
541
476
418
1,623
1,564
1,507
29,445
27,443
27,44329,4451,5071,5641,6234184765416267188098999891,0786306887548248959668248829286085085275084971259371735744411611709609609769741,0243545826156217809791,0861,2001,3211,4171,2191,3391,4581,7111,8921,9962,0771,9491,5582970000000000000006790727727679683604644525541533476519510300200200300200100100200200300200300300500400200100170170300140901001000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
10
60
100
140
130
100
100
200
200
200
200
200
100
100
100
100
100
200
200
200
200
200
290
299
278
266
266
252
317
288
347
342
307
273
224
224
0
0
0
0
0
0
0
0
0
0
282
0
0
290
297
297
1,451
1,932
2,063
1,983
1,880
1,699
1,446
1,327
1,193
1,148
1,052
931
817
710
511
421
396
371
323
303
254
249
223
223
155
157
37
38
51
67
65
75
107
483
494
501
482
582
905
859
800
943
872
801
731
665
607
1,055
966
876
786
695
603
518
453
395
1,600
1,541
1,484
1,641
1,577
1,5771,6411,4841,5411,6003954535186036957868769661,0556076657318018729438008599055824825014944831077565675138371571552232232492543033233713964215117108179311,0521,1481,1931,3271,4461,6991,8801,9832,0631,9321,4512972972900028200000000002242242733073423472883172522662662782992902002002002002001001001001001002002002002002001001001301401006010000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
178
178
178
178
178
178
178
178
178
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,809
5,185
5,1855,809000000000000000000000000000000000000000001781781781781781781781781780000000000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
700
700
700
700
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000070070070070000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
204
204
183
216
259
257
290
287
308
308
392
426
446
446
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
178
178
178
178
178
178
178
178
178
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,869
20,562
20,56221,8690000000000000000000000000000000000000000017817817817817817817817817800000000000000000000000004464464263923083082872902572592161832042040000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
301
107
18
14
13
12
12
12
12
26
269
269
269
269
269
269
201
218
210
31
721
720
727
737
15
15
4
4
6
6
6
6
18
18
14
14
26
26
26
23
23
24
23
23
23
23
23
23
23
23
23
23
23
23
23
302
23
23
23
23
21,995
20,681
20,68121,9952323232330223232323232323232323232323242323262626141418186666441515737727720721312102182012692692692692692692612121212131418107301000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
0
900
200
0
100
200
200
240
1,000
3,960
630
300
400
500
800
700
1,100
1,500
1,000
2,900
2,900
3,900
1,200
1,500
2,200
2,800
3,500
4,800
4,378
4,149
4,141
4,162
5,864
5,525
6,327
8,752
11,143
13,307
15,400
16,183
16,901
16,901
0
0
0
0
0
0
0
0
0
0
10
9
0
3
729
729
1,632
1,760
1,688
1,318
816
677
621
784
574
449
531
501
686
441
532
1,200
400
236
417
443
395
417
395
395
229
584
1,027
773
1,232
984
9,588
15,341
25,498
17,499
15,842
17,766
15,400
14,224
20,249
16,958
12,778
29,943
22,248
5,464
4,672
4,243
3,686
3,624
4,412
6,172
5,748
3,281
3,763
3,271
3,152
2,230
3,524
4,561
4,957
20,972
20,657
20,65720,9724,9574,5613,5242,2303,1523,2713,7633,2815,7486,1724,4123,6243,6864,2434,6725,46422,24829,94312,77816,95820,24914,22415,40017,76615,84217,49925,49815,3419,5889841,2327731,0275842293953954173954434172364001,2005324416865015314495747846216778161,3181,6881,7601,63272972930910000000000016,90116,90116,18315,40013,30711,1438,7526,3275,5255,8644,1624,1414,1494,3784,8003,5002,8002,2001,5001,2003,9002,9002,9001,0001,5001,1007008005004003006303,9601,00024020020010002009000000
   > Total Current Liabilities 
0
0
0
0
900
200
30
200
200
200
240
900
3,960
630
400
400
400
800
700
1,100
1,500
900
1,100
1,400
3,100
1,200
1,000
1,200
1,100
1,000
1,600
1,195
919
857
825
1,471
1,076
1,831
3,191
5,534
2,462
2,875
3,482
5,023
5,023
0
0
0
0
0
0
0
0
0
0
10
9
0
3
729
729
1,282
1,160
1,688
1,318
816
677
621
647
452
274
426
360
560
332
500
1,183
398
234
417
443
395
417
395
395
229
584
1,027
773
1,232
984
9,588
15,341
25,498
17,301
15,575
17,526
15,173
14,010
19,757
16,488
12,330
17,525
9,793
5,087
4,319
3,914
3,384
2,962
3,811
5,633
5,275
2,876
3,429
3,010
2,966
2,122
2,098
3,160
3,554
10,976
13,264
13,26410,9763,5543,1602,0982,1222,9663,0103,4292,8765,2755,6333,8112,9623,3843,9144,3195,0879,79317,52512,33016,48819,75714,01015,17317,52615,57517,30125,49815,3419,5889841,2327731,0275842293953954173954434172343981,1835003325603604262744526476216778161,3181,6881,1601,2827297293091000000000005,0235,0233,4822,8752,4625,5343,1911,8311,0761,4718258579191,1951,6001,0001,1001,2001,0001,2003,1001,4001,1009001,5001,1007008004004004006303,960900240200200200302009000000
       Short-term Debt 
0
0
0
0
800
100
0
0
0
0
0
0
0
0
0
200
0
0
0
0
0
0
0
0
0
0
0
100
100
0
600
0
0
0
0
0
0
0
2,000
4,000
0
0
475
1,000
1,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200
200
400
900
0
900
0
0
0
0
0
17
17
17
17
24
0
88
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
225
233
241
249
258
268
278
287
297
196
175
124
194
184
18419412417519629728727826825824924123322500000000000000000000000000000088024171717170000090009004002002000000000000000001,0001,000475004,0002,00000000006000100100000000000002000000000001008000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
225
0
0
0
0
0
0
0
0
0
0
0
68
56
566800000000000225000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
200
100
0
200
200
0
0
600
0
0
200
100
200
200
400
400
300
500
800
900
2,600
700
500
600
600
500
600
773
519
509
476
1,235
840
1,595
955
856
2,103
2,263
2,355
0
2,599
0
0
0
0
0
0
0
0
0
0
214
0
0
185
540
540
711
730
728
1,007
637
501
575
523
371
256
400
335
343
307
266
355
287
193
388
316
278
390
395
395
213
584
142
773
1,079
873
996
1,559
8,686
6,026
4,413
4,597
4,556
4,242
1,993
3,796
1,723
1,097
2,020
1,493
1,217
879
1,034
766
1,523
2,452
2,315
1,247
1,025
992
886
621
568
1,255
524
1,354
1,003
1,0031,3545241,2555686218869921,0251,2472,3152,4521,5237661,0348791,2171,4932,0201,0971,7233,7961,9934,2424,5564,5974,4136,0268,6861,5599968731,0797731425842133953953902783163881932873552663073433354002563715235755016371,0077287307115405401850021400000000002,59902,3552,2632,1038569551,5958401,2354765095197736005006006005007002,600900800500300400400200200100200006000020020001002000000
       Other Current Liabilities 
0
0
0
0
-100
0
30
0
0
200
240
300
3,960
630
200
100
200
600
300
700
1,200
400
300
500
500
500
500
500
400
500
400
422
400
349
349
236
236
236
236
678
360
612
652
0
1,424
0
0
0
0
0
0
0
0
0
0
10
9
0
3
189
189
371
30
59
310
179
176
46
124
81
18
8
7
199
8
210
828
111
41
29
127
117
27
0
0
16
0
885
0
153
111
8,592
13,782
16,812
11,275
11,162
12,929
10,617
9,768
17,764
12,692
10,607
16,428
7,773
3,594
3,102
3,035
2,350
1,971
2,055
2,940
2,711
1,371
2,136
1,740
1,793
1,204
1,334
1,730
2,906
9,428
12,077
12,0779,4282,9061,7301,3341,2041,7931,7402,1361,3712,7112,9402,0551,9712,3503,0353,1023,5947,77316,42810,60712,69217,7649,76810,61712,92911,16211,27516,81213,7828,59211115308850160027117127294111182821081997818811244617617931059303711891893091000000000001,42406526123606782362362362363493494004224005004005005005005005003004001,2007003006002001002006303,96030024020000300-1000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50
30
30
30
20
10
1,760
1,580
880
0
500
1,040
1,570
2,600
3,140
3,180
3,230
3,280
3,330
4,400
4,450
4,500
5,560
5,610
10,850
12,520
12,700
0
11,880
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
400
350
600
0
0
0
0
0
137
122
175
106
142
127
109
32
17
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
198
267
240
227
214
492
470
448
12,418
12,455
377
353
329
302
662
601
539
473
405
334
261
186
108
1,426
1,401
1,403
9,996
7,393
7,3939,9961,4031,4011,42610818626133440547353960166230232935337712,45512,4184484704922142272402671980000000000000002217321091271421061751221370000060035040000000000000000011,880012,70012,52010,8505,6105,5604,5004,4504,4003,3303,2803,2303,1803,1402,6001,5701,04050008801,5801,7601020303030500000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,992
12,053
12,112
12,173
12,234
12,296
12,357
12,419
12,481
12,544
12,606
12,669
12,733
12,798
0
0
0
0
0
0
00000012,79812,73312,66912,60612,54412,48112,41912,35712,29612,23412,17312,11212,05311,992000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
137
122
175
93
132
122
108
32
17
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
198
267
240
227
214
492
470
448
426
402
377
353
329
302
0
0
0
0
0
0
3,271
0
0
0
4,561
0
8,416
5,879
5,8798,41604,5610003,2710000003023293533774024264484704922142272402671980000000000000002217321081221329317512213700000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
353
329
0
0
0
0
0
0
0
0
0
0
0
0
0
21,869
20,562
20,56221,8690000000000000329353000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
0
4,100
4,200
2,900
1,700
4,500
3,200
1,130
-600
-1,000
-150
3,000
1,800
2,000
4,900
3,900
1,700
2,000
100
-1,600
-2,200
-3,700
4,800
1,600
700
-500
-1,700
-3,200
671
2,212
-201
-695
-414
-1,918
-2,825
-5,507
-9,086
-10,982
-13,109
-14,393
0
-15,386
0
0
0
0
0
0
0
0
0
0
-10
-9
50
-3
11,786
11,786
9,054
7,559
11,946
9,524
8,596
7,529
6,765
5,912
5,159
4,626
3,544
2,772
3,842
4,239
3,579
6,005
9,121
8,439
7,059
7,906
6,850
5,409
13,028
13,028
9,398
6,369
15,230
11,758
8,057
3,757
9,556
-1,625
-13,661
25,868
16,051
6,258
2,294
-4,476
3,845
2,569
4,830
-4,788
-1,496
8,926
5,686
8,501
29,364
25,880
22,441
17,411
14,365
11,484
8,703
6,682
8,031
79,598
76,505
73,334
65,408
68,027
61,674
61,67468,02765,40873,33476,50579,5988,0316,6828,70311,48414,36517,41122,44125,88029,3648,5015,6868,926-1,496-4,7884,8302,5693,845-4,4762,2946,25816,05125,868-13,661-1,6259,5563,7578,05711,75815,2306,3699,39813,02813,0285,4096,8507,9067,0598,4399,1216,0053,5794,2393,8422,7723,5444,6265,1595,9126,7657,5298,5969,52411,9467,5599,05411,78611,786-350-9-100000000000-15,3860-14,393-13,109-10,982-9,086-5,507-2,825-1,918-414-695-2012,212671-3,200-1,700-5007001,6004,800-3,700-2,200-1,6001002,0001,7003,9004,9002,0001,8003,000-150-1,000-6001,1303,2004,5001,7002,9004,2004,1000000
   Common Stock
0
0
0
0
0
0
0
0
0
10,470
10,470
0
12,290
80
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
300
273
279
281
281
288
289
290
292
290
291
296
296
0
296
300
0
0
0
0
0
0
0
300
20
1
2
3
3
49
49
17
17
20
20
21
21
21
21
21
21
21
22
22
23
23
26
28
28
31
33
33
33
44
44
45
45
58
58
58
58
72
73
73
91
91
91
91
92
117
118
128
129
129
129
130
5
15
16
17
17
17
18
19
20
29
132
132
132
132
158
16
161581321321321322920191817171716155130129129129128118117929191919173737258585858454544443333333128282623232222212121212121212020171749493321203000000000300296029629629129029229028928828128127927330000000000000000008012,290010,47010,470000000000
   Retained Earnings Total Equity0000-262,748-259,553-248,094-244,975-242,289-238,967-235,537-232,394-227,141-223,432-219,461-204,545-200,803-196,545-194,170-196,959-179,135-174,880-172,034-169,659-161,305-155,624-144,779-133,797-127,023-113,400-101,042-94,562-89,652-85,096-81,258-77,034-73,666-71,169-68,941-56,875-54,945-53,073-51,873-48,689-47,59100000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
-10
0
-50
-70
-100
-100
-100
-100
-100
-200
-200
-200
-200
-200
-200
-200
-200
-300
-300
-300
-300
-312
-338
-365
-393
-235
-262
-293
-324
-355
-391
-427
-461
-333
-333
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-33
-33
-33
-142
-233
-233
-233
-522
-592
-682
-766
-888
-986
-1,056
-1,126
-1,191
-1,139
-356
-380
-405
-372
-392
-239
-251
-242
-242
-178
-173
-19
-22
-26
-32
-39
-47
-58
-72
-105
-123
-154
-191
-186
-243
-303
-358
-429
-500
-570
-636
-695
-757
-817
-877
-887
-945
-1,003
-1,056
0
0
0
0
0
181
-1,317
-1,31718100000-1,056-1,003-945-887-877-817-757-695-636-570-500-429-358-303-243-186-191-154-123-105-72-58-47-39-32-26-22-19-173-178-242-242-251-239-392-372-405-380-356-1,139-1,191-1,126-1,056-986-888-766-682-592-522-233-233-233-142-33-33-3300000000000000-333-333-461-427-391-355-324-293-262-235-393-365-338-312-300-300-300-300-200-200-200-200-200-200-200-200-100-100-100-100-100-70-500-100000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
56,683
57,099
58,901
60,946
61,762
62,251
81,925
82,612
83,019
83,358
96,430
96,796
97,651
98,261
110,526
111,702
113,289
159,574
160,739
161,791
163,508
165,091
175,762
177,331
183,837
192,042
192,545
193,230
194,186
200,807
230,754
231,817
232,211
232,485
232,580
233,735
234,860
236,320
240,821
339,019
339,121
339,223
336,560
0
0
00336,560339,223339,121339,019240,821236,320234,860233,735232,580232,485232,211231,817230,754200,807194,186193,230192,545192,042183,837177,331175,762165,091163,508161,791160,739159,574113,289111,702110,52698,26197,65196,79696,43083,35883,01982,61281,92562,25161,76260,94658,90157,09956,68300000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
6,500
7,200
7,300
7,600
10,800
330
340
11,600
380
15,350
20,700
21,500
23,300
27,900
28,500
28,500
31,500
33,100
33,300
34,200
34,900
56,700
55,700
56,200
56,300
56,800
56,700
74,120
77,364
77,010
78,099
80,501
80,843
82,993
83,187
83,476
85,007
86,947
87,273
0
88,089
0
0
0
0
0
0
0
0
0
11
10
9
47
22
0
20,545
34,833
35,459
43,002
43,902
44,746
45,396
45,617
45,967
46,178
46,392
46,522
46,908
47,068
48,261
48,418
52,246
57,064
57,504
59,273
61,338
62,001
62,502
0
82,167
83,197
83,531
96,449
96,818
97,677
98,293
110,565
111,749
113,347
159,646
160,844
161,914
163,662
165,282
175,948
177,574
184,140
180,408
192,974
193,730
194,756
201,443
231,449
232,574
233,028
233,362
233,467
234,680
235,863
237,376
240,821
339,019
339,121
339,223
336,560
343,245
343,500
343,500343,245336,560339,223339,121339,019240,821237,376235,863234,680233,467233,362233,028232,574231,449201,443194,756193,730192,974180,408184,140177,574175,948165,282163,662161,914160,844159,646113,347111,749110,56598,29397,67796,81896,44983,53183,19782,167062,50262,00161,33859,27357,50457,06452,24648,41848,26147,06846,90846,52246,39246,17845,96745,61745,39644,74643,90243,00235,45934,83320,545022479101100000000088,089087,27386,94785,00783,47683,18782,99380,84380,50178,09977,01077,36474,12056,70056,80056,30056,20055,70056,70034,90034,20033,30033,10031,50028,50028,50027,90023,30021,50020,70015,35038011,60034033010,8007,6007,3007,2006,5000000



Balance Sheet

Currency in USD. All numbers in thousands.